MultiPlan Corporation Class A Common Stock MPLN 深 滬
等待開盤 08-06 09:30:00 美东时间
23.15
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 23.15
- 總市值 3.74亿
- 52周最高 37.608
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 4.80
- 委 比 0.00%
- 總股本 1617.12万
- 歷史最高 517.20
- 量 比 0
- 振 幅 0.00%
- 歷史最低 6.92
- 每 手 1
- 風險率 5.70%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Helius Medical Technologies Announces Additional Authorized Claim For Payment For PoNS Device From CignaHealth
- CignaHealth becomes fifth major payer to authorize claim for PoNS Device at out-of-network adjusted negotiated list price of $19,161--This follows another recent authorization by Anthem Multiplan for PoNS Device at
06-16 19:12
Judge rules against health insurers in price-fixing case filed by healthcare providers
A federal judge in Chicago ruled that health insurers, including Cigna (NYSE:CI), UnitedHealth Group (NYSE:UNH), and CVS Health (NYSE:CVS) subsidiary Aetna must face lawsuits accusing them of conspiri...
06-05 02:51
MultiPlan shares are trading lower following a Q4 revenue miss.
MultiPlan shares are trading lower following a Q4 revenue miss.
02-25 22:29
Multiplan reports Q4 results
Multiplan press release (NYSE:MPLN): Q4 net loss of $138.0 million, compared to net loss of $31.4 million. Revenue of $232.1M (-4.9% Y/Y). 2025 Financial Guidance Financial Metric Full Year 2025 G...
02-25 19:07
Claritev (MultiPlan) 2025 Outlook: Expects Revenues To Be (2)% To Flat YoY, And Sees Adj. EBITDA Margin Of 62.5%-63.5%
2025 Financial Guidance1Financial Metric Full Year 2025 GuidanceRevenues (2)% to flat from FY 2024Adjusted EBITDA Margin1 62.5% to 63.5%Capital expenditures $155 million to
02-25 19:06
Earnings Scheduled For February 25, 2025
Companies Reporting Before The Bell • Super Group (SGHC) (NYSE:SGHC) is estimat...
02-25 16:32
MultiPlan Rebrands to Claritev, Shifts Strategic Focus
MultiPlan ( ($MPLN) ) has issued an update. On February 17, 2025, MultiPlan Cor...
02-20 05:50
MultiPlan Completes Major Financial Restructuring in 2025
An update from MultiPlan ( ($MPLN) ) is now available. On January 30, 2025, Mul...
01-31 06:48
美股大行评级 | 潜在涨幅71%！阿里巴巴获花旗上调目标价至138美元，维持“买入”评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1084758333929132032.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.：维持Inozyme Pharma(INZY)"买入"评级，目标价从14美元升至16美元</p> <p>• Maxim Group：上调Reviva Pharmaceutica
01-13 09:38
MultiPlan and J2 Health announces strategic agreement
MultiPlan (NYSE:MPLN) has announced an agreement with J2 Health, a cloud-based software solution that optimizes provider network performance. This strategic agreement will support MultiPlan’s network ...
01-11 01:40
